Design and Evaluation of a Gamification-Based Mobile Application for Reporting Adverse Drug Reactions by Patients and Healthcare Professionals: A Pilot Usability Study in Diabetes Care
Drug, Healthcare and Patient Safety · Published 2026-07-01 · DOI 10.2147/dhps.s618861
Free full text
Authors (3)
Kimia Mahini, Rezvan Rahimi, Zohreh Vanaki
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Mahini, K., Rahimi, R., Vanaki, Z. (2026). Design and Evaluation of a Gamification-Based Mobile Application for Reporting Adverse Drug Reactions by Patients and Healthcare Professionals: A Pilot Usability Study in Diabetes Care. Drug, Healthcare and Patient Safety. https://doi.org/10.2147/dhps.s618861
Related articles
- Assessing Readability and Usability of Electronic Medicine Package Leaflets in South Korea: A Mixed-Methods Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
- Obstructive Fibrinous Tracheal Pseudomembrane Following Repeated Intratracheal Interventions · Drug, Healthcare and Patient Safety · 2024 · Same journal
- Paracetamol Overdose in Somali Children Under Five: An Emerging Public Health Concern · Drug, Healthcare and Patient Safety · 2025 · Same journal
- Assessment of Knowledge, Attitudes, and Practices on Antibiotic Use and Resistance Among Healthcare Workers in Monrovia, Liberia: A Facility-Based Cross-Sectional Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
- Prevalence of Missed Medication Doses and Outcomes of Hospitalized Patients Living with HIV in Uganda · Drug, Healthcare and Patient Safety · 2026 · Same journal
- Establishing of a National Diagnostic Reference Level for Radiation Dose in Digital Paediatric Pelvic X-Rays in Jordan: A Multicenter Retrospective Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
- The Prevalence and Severity of Potential Drug–Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital · Drug, Healthcare and Patient Safety · 2023 · Same journal
- Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome · Drug, Healthcare and Patient Safety · 2024 · Same journal
- Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal · Drug, Healthcare and Patient Safety · 2023 · Same journal
- Current Status and Research Trends in Deprescribing: A Bibliometric Review · Drug, Healthcare and Patient Safety · 2025 · Same journal